Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: ELAN

Elanco Animal Health Incorporated

Healthcare | Drug Manufacturers - Specialty & Generic
$26.20 +0.29 (+1.12%) as of 2026-09-05 08:22 UTC
Market Cap$13.0B
Volume336.4K
EPS (TTM)$-0.47

Elanco Animal Health Incorporated (NYSE: ELAN) is a $13.0B drug manufacturers - specialty & generic company trading at $26.20 (+1.1% today). Figures from SEC EDGAR and market feeds; updated 2026-09-05 08:22 UTC.

52-Week Range
Low $19.40High $26.33

What Elanco Animal Health Incorporated does

This company operates in animal health, producing products for both pet and farm animals including antibiotics, antiparasitic treatments like the Seresto collar, and ionophore-based products. The business faces competition from generic alternatives as patents expire, with a competitor already selling a generic version of Seresto in the U.S. before certain patent protections end.

Summarized from Elanco Animal Health Incorporated’s SEC filings · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Quote
Price$26.20
Change (1D)+0.29 (+1.12%)
Market cap$13.0B
Volume336.4K shares
52-week range$19.40 – $26.33
Valuation
EPS (TTM)$-0.47
Price/book1.99×
Debt/equity0.60
Returns
52-week return+35.0%

Revenue Trend

FY2021: $4.76B$4.76BFY2021FY2022: $4.41B$4.41BFY2022FY2023: $4.42B$4.42BFY2023FY2024: $4.44B$4.44BFY2024FY2025: $4.71B$4.71BFY2025
Annual Revenue · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-08-25
  • 2026-08-25VanHimbergen Robert MEVP and CFOA8$197
  • 2026-08-25Modi Rajeev A.SEE REMARKSA61$1.5K
  • 2026-08-25Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORA117$2.8K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Elanco Animal Health Incorporated do?

This company operates in animal health, producing products for both pet and farm animals including antibiotics, antiparasitic treatments like the Seresto collar, and ionophore-based products.

What is ELAN's valuation?

ELAN trades at $26.20, as of 2026-09-05.

When did ELAN last file with the SEC?

Elanco Animal Health Incorporated's most recent SEC filing on record is a 8-K filed 2026-05-27. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-09-05 08:22 UTC. This page is also available as JSON at /api/data?ticker=ELAN and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ELAN and 5,000+ tickers.

Create a free account — keep ELAN
For your agent
GET /api/data?ticker=ELAN

This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt